Insulin Regimen for Patients with Impaired Renal Function

Initial Dosing and Conversion Strategy

The American Diabetes Association recommends starting with 10 units per day or 0.1-0.2 units/kg per day when initiating NPH insulin in the morning for patients with impaired renal function 2, 3
When converting from bedtime NPH to morning NPH, the American Diabetes Association suggests using 80% of the current bedtime NPH dose to reduce hypoglycemia risk 1, 4

The American Diabetes Association recommends setting appropriate fasting plasma glucose goals based on individual factors, considering the increased risk of hypoglycemia in renal impairment, and using an evidence-based titration algorithm: increase by 2 units every 3 days until reaching target FPG without hypoglycemia 1, 2
If hypoglycemia occurs, the American Diabetes Association advises determining the cause; if no clear reason is identified, reduce the dose by 10-20% 2, 4

Patients with impaired renal function have an increased risk of hypoglycemia due to decreased insulin clearance and impaired renal gluconeogenesis, according to the American Diabetes Association 5
Morning NPH administration allows for better monitoring of glucose response during waking hours, reduced risk of undetected nocturnal hypoglycemia, and a more predictable insulin action profile in the setting of variable renal function, as recommended by the American Diabetes Association 2, 5

The American Diabetes Association recommends assessing the adequacy of insulin dose at every visit and monitoring for clinical signals of overbasalization, including elevated bedtime-to-morning glucose differential, hypoglycemia, and high glucose variability 1, 2
Consider more frequent blood glucose monitoring in patients with renal impairment, particularly during initial titration, as suggested by the American Diabetes Association 5

If glycemic targets are not achieved with once-daily morning NPH, the American Diabetes Association recommends considering adding a GLP-1 receptor agonist or converting to a twice-daily NPH regimen, with dose adjustments for renal function 1, 2
Consider switching to a long-acting basal analog if the patient experiences frequent hypoglycemia despite dose adjustments, as advised by the American Diabetes Association 2, 3

Avoid bedtime NPH in patients with impaired renal function due to increased risk of undetected nocturnal hypoglycemia, according to the American Diabetes Association 2, 5
Be aware that insulin requirements may fluctuate with changes in renal function, requiring more frequent monitoring and dose adjustments, as recommended by the American Diabetes Association 5
Consider prescription of glucagon for emergent hypoglycemia, particularly important for patients with renal impairment, as suggested by the American Diabetes Association 2, 3